Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Risk Factors for Recurrence of Follicular Thyroid Cancer: A Systematic Review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Effects of supplemental vitamin D on muscle performance and quality of life in Graves' disease. A randomized clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Thyroid peroxidase antibodies and prospective live birth rate: A cohort study of women with recurrent pregnancy loss

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Alexithymia, Emotional Distress, and Perceived Quality of Life in Patients With Hashimoto's Thyroiditis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Frederik A Verburg
  • Markus Luster
  • Cristina Cupini
  • Luca Chiovato
  • Leonidas Duntas
  • Rossella Elisei
  • Ulla Feldt-Rasmussen
  • Harald Rimmele
  • Ettore Seregni
  • Johannes W A Smit
  • Christian Theimer
  • Luca Giovanella
Vis graf over relationer
Background: Even though the presence of antithyroglobulin antibodies (TgAbs) represents a significant problem in the follow-up of patients with differentiated thyroid cancer (DTC), the current guidelines on the management of DTC that have been published in recent years contain no text concerning the methods to be used for detecting such antibody-related interference in thyroglobulin (Tg) measurement or how to manage TgAb-positive patients in whom Tg cannot be used reliably as a tumor marker. Aim: An international group of experts from the European Thyroid Association Cancer Research Network who are involved in the care of DTC patients met twice to form a consensus opinion on how to proceed with treatment and follow-up in TgAb-positive DTC patients based on the available evidence in the literature. Here we will report on the consensus opinions that were reached regarding technical and clinical issues. Results: This clinical opinion article provides an overview of the available evidence and the resulting consensus recommendations. The current literature does not provide sufficient data for giving evidence-based answers to many questions arising in the care of TgAb-positive DTC patients. Where insufficient evidence was available, a thorough discussion by a group of physician-scientists, all of whom have a distinguished track record in thyroid cancer care, was held to arrive at a consensus expert opinion. The questions and answers discussed were then summarized into an algorithm for the management of TgAb-positive patients. Conclusion: We were able to define 26 consensus expert recommendations and a resulting algorithm for the care of TgAb-positive DTC patients.
OriginalsprogEngelsk
TidsskriftThyroid
Vol/bind23
Udgave nummer10
Sider (fra-til)1211-25
Antal sider15
ISSN1050-7256
DOI
StatusUdgivet - okt. 2013

ID: 39031378